TickerFactsScreenerDevelopers

RELMADA THERAPEUTICS, INC. (RLMD) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2021: $-7.162022: $-5.302023: $-3.282024: $-2.652025: $-1.45$-1.45
2021EPS (Diluted) (USD/shares)2025
Fiscal YearEPS (Diluted)Change YoY
2025$-1.45+45.3%
2024$-2.65+19.2%
2023$-3.28+38.1%
2022$-5.30+26.0%
2021$-7.16—